Medical research

Another step toward sickle cell disease treatment

(Medical Xpress)—A compound discovered at Virginia Commonwealth University has taken yet another step closer to becoming the only approved drug in the world that is therapeutically effective in managing adult sickle cell ...

Oncology & Cancer

Artificial gene defect reveals target to fight genetic disease

Fanconi anemia (FA) is caused by defective genes for DNA-repair leading to bone marrow failure, developmental abnormalities and increased cancer risk. Using genome-wide genetic approaches, researchers at CeMM systematically ...

Diseases, Conditions, Syndromes

Hospital-acquired anemia more common, increases risks

One in three patients hospitalized for medical problems experienced a drop in their red blood cell count due to the hospitalization - a concept called hospital-acquired anemia, new research showed.

Oncology & Cancer

DDX41 and its unique contribution to myeloid leukemogenesis

In an editorial paper published in Oncotarget titled, "DDX41 and its unique contribution to myeloid leukemogenesis," researcher Hirotaka Matsui from the National Cancer Center Hospital in Tokyo, Japan, and Kumamoto University ...

page 27 from 27